Introduction
============

Colorectal cancer (CRC) is a type of cancer that is most associated with dietary factors, and has the third highest mortality rate of common malignancies in males and females ([@b1-ol-0-0-6992]--[@b3-ol-0-0-6992]). Due to the continued urbanization of the population, the morbidity and mortality rates associated with CRC are increasing gradually worldwide. In addition to genetic factors, eating habits and environmental factors markedly influence the relative risk for the occurrence, and development of colon cancer ([@b4-ol-0-0-6992],[@b5-ol-0-0-6992]). Although CRC incidence rates have decreased to a certain degree, there is certain evidence indicating that current therapies are expensive and induce debilitating side effects; in addition, recurrence rates of \>50% have been reported, primarily due to the development of acquired chemoresistance to conventional chemotherapeutic regimens ([@b6-ol-0-0-6992],[@b7-ol-0-0-6992]).

Grape seeds are an effective source of proanthocyanidins ([@b8-ol-0-0-6992]). Grape seed proanthocyanidins (GSPs) are primarily composed of dimers, trimers and oligomers of monomeric anthocyanidin ([@b9-ol-0-0-6992],[@b10-ol-0-0-6992]). There are a number of biological functions of GSPs, including antimutagenic, anti-inflammatory, anti-angiogenic and anticarcinogenic activities ([@b11-ol-0-0-6992]--[@b15-ol-0-0-6992]). Previous studies have demonstrated that GSPs have cytotoxic effects in numerous cancer cell lines; however, the mechanisms underlying these anticancer effects remain uncharacterized ([@b16-ol-0-0-6992]--[@b18-ol-0-0-6992]).

Apoptosis, or programmed cell death, serves a key role in regulating the development and growth of normal cells, and is often dysregulated in cancer cells ([@b19-ol-0-0-6992]). p53, the tumor suppressor protein, serves an essential role in apoptosis and acts as a suppressor of transformation ([@b20-ol-0-0-6992],[@b21-ol-0-0-6992]), in addition, the expression level of p53 has been revealed to be induced by DNA damage ([@b22-ol-0-0-6992]). In turn, p53 orchestrates a global transcriptional response that counters cell proliferation or induces apoptosis ([@b23-ol-0-0-6992]--[@b25-ol-0-0-6992]). GSPs have been demonstrated to protect against stress-induced changes in the expression levels of p53 and the anti-apoptotic protein, B cell lymphoma-2 (Bcl-2), in human oral epithelial ([@b26-ol-0-0-6992]), and liver ([@b27-ol-0-0-6992]) cells. The Bcl-2 family of proteins consists of pro- and anti-apoptotic regulators of apoptosis. The established mode of action of each separate entity involves protecting or disrupting mitochondrial integrity, thereby activating, or inhibiting the release of downstream factors, including cytochrome *c* from the mitochondrion; these stimulate apoptosis ([@b28-ol-0-0-6992]). The apoptosis regulator Bax (Bax) and Bcl-2 homologous antagonist/killer (Bak) genes encode apoptosis-promoting members of the Bcl-2 gene family. The Bcl-2 protein is known to form heterodimers with the Bax protein *in vivo* and the molar ratio of Bcl-2 to Bax determines whether apoptosis is induced or inhibited in target tissues ([@b29-ol-0-0-6992]). The Bax protein, considered to be one of the primary targets of p53, controls cell death by its participation in the disruption of mitochondria and the subsequent release of cytochrome *c* ([@b30-ol-0-0-6992]). Bak also regulates the release of cytochrome *c*. Cytochrome *c* release, in turn, activates caspase-9 and −3 ([@b31-ol-0-0-6992]). Cleaved caspase-3 is regarded as a proximate mediator of apoptosis, whereas caspase-2 triggered Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol ([@b32-ol-0-0-6992]). Caspase family proteins serve a key role in the downstream events involved in p53-mediated apoptosis ([@b33-ol-0-0-6992]). Clustering of the initiator caspases activates the effector caspases, which trigger apoptosis ([@b34-ol-0-0-6992]).

The present study investigated the molecular mechanisms underlying GSP-induced apoptosis in the HCT-116 colon cancer cell line. Exposure of these cells to various concentrations of GSPs resulted in profound changes in morphology, proliferation and apoptosis. The present study investigated the involvement of p53, cytochrome *c*, Bcl-2 family proteins and caspases in this process, and the results indicated that GSPs may provide a novel approach to the treatment of CRC.

Materials and methods
=====================

### Cell lines and culture

The HCT-116 human CRC cell line (Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China) was cultured with McCoy\'s 5A (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA), 100 IU penicillin and 100 µg/ml streptomycin (Invitrogen; Thermo Fisher Scientific, Inc.) in a humidified incubator at 37°C in 5% CO~2~. The HF-91 human fibroblast cell line (Type Culture Collection of the Chinese Academy of Sciences) was cultured in DEME/H (Sigma-Aldrich; Merck KGaA) supplemented with 10% (vol/vol) heat-inactivated FBS (Gibco; Thermo Fisher Scientific, Inc.), 100 IU penicillin and 100 µg/ml streptomycin (Invitrogen; Thermo Fisher Scientific, Inc.) in a humidified incubator at 37°C in 5% CO~2~. HCT-116 and HF-91 cells were plated in 96-well cell culture plates at 5×10^3^ cells/well, and incubated for 24 h. Triplicate wells were then treated with GSPs at various concentrations (25, 50 or 100 µg/ml), 25 µg/ml 5-fluorouracil (5-Fu) as a positive control or PBS as the negative solvent control for 48 h prior to the analyses described below.

### Reagents and antibodies

GSPs were purchased from Sigma-Aldrich (Merck KGaA; 20315-25-7). The antibodies used for western blotting were as follows: Mouse anti-caspase-2 (sc-5292), mouse anti-caspase-3 (sc-7272), mouse anti-caspase-9 (sc-56073), mouse anti-Bcl-2 (sc-7382), mouse anti-Bax (sc-20067), mouse anti-β-actin (sc-47778), rabbit anti-Bak (sc-7873), rabbit anti-mouse IgG-horseradish peroxidase (HRP; sc-358914) and mouse anti-rabbit IgG-HRP (sc-2357). All antibodies were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA).

### Cell viability

HCT-116 and HF-91 cells were plated in 96-well cell culture plates at 5×10^3^ cells/well and incubated for 24 h at 37°C. Triplicate wells were then treated with GSPs at various concentrations (25, 50 or 100 µg/ml), 25 µg/ml 5-Fu as a positive control or PBS as the negative solvent control. Cell viability was determined after 48 h by adding 10 µl (5 mg/ml) cell proliferation reagent (MTT; Sigma-Aldrich; Merck KGaA) and incubating for 24 h at 37°C until a purple precipitate was visible. The precipitate was then solubilized by adding dimethyl sulfoxide (Sigma-Aldrich; Merck KGaA). The absorbance was evaluated at 570 nm using a microplate reader. The percentage inhibition of cell viability was determined using the following formula: Percentage inhibition=1-optical density (OD)~treatment\ group~/OD~solvent\ control~ ×100%.

### Annexin V analysis

Annexin V and fluorescein isothiocyanate (FITC) staining was performed using a commercial Annexin V-FITC kit (BD Biosciences, Franklin Lakes, NJ, USA). Briefly, cells were treated with GSPs (25, 50 or 100 µg/ml), 25 µg/ml 5-Fu as a positive control or PBS as a solvent control for 48 h. The cells were then harvested, washed twice with cold PBS and resuspended in binding buffer at a concentration of 5×10^5^ cells/ml. A 100-µl aliquot containing 5×10^4^ cells was incubated in the dark with 5 µl Annexin V-FITC and 5 µl propidium iodide (PI) at room temperature for 15 min. Subsequently, 400 µl binding buffer was added and the cells were viewed (5 fields for each group) using a fluorescence microscope (Olympus Corporation, Tokyo, Japan) at magnification ×400. Viable cells were stained green and apoptotic cells were stained red. This experiment was repeated three times.

### JC-1 assay

JC-1 analysis was performed using a commercial Mitochondrial Membrane Potential Detection JC-1 kit (BD Biosciences). Briefly, cells were treated with GSPs (25, 50 or 100 µg/ml), 25 µg/ml 5-Fu as a positive control or PBS as a solvent control for 48 h prior to harvesting, washing twice with cold PBS and resuspending in binding buffer at a concentration of 1×10^6^ cells/ml. A 100-µl aliquot was incubated with 5 µl JC-1 and 5 µl PI in the dark at room temperature for 15 min. Subsequently, 400 µl binding buffer was added and the cells were analyzed using a flow cytometer (Beckman Coulter, Inc., Brea, CA, USA). Cells negative for JC-1 and PI were considered to be viable; JC-1+/PI+ cells were in early apoptosis; JC-1+/PI- cells were necrotic or in late apoptosis. This experiment was repeated three times.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total RNA was isolated from treated cells using TRIzol^®^ reagent (Invitrogen; Thermo Fisher Scientific, Inc.). First-strand cDNA was reverse transcribed using the PrimeScript™ RT reagent kit (Takara Bio, Inc., Otsu, Japan), in accordance with the manufacturer\'s protocols. Relative expression levels of mRNA were determined by qPCR using the primer sequences presented in [Table I](#tI-ol-0-0-6992){ref-type="table"} and a Thermo^®^ PikoReal 96 system (Thermo Fisher Scientific., Inc.). GAPDH was used as the endogenous reference gene. cDNA was subjected to 40 PCR cycles of 94°C for 30 sec, 60°C for 30 sec and 72°C for 45 sec using FastStart Universal SYBR Green Master (Roche Diagnostics, Basel, Switzerland). Experiments were performed in triplicate and data were analyzed using Pikoreal software version 2.1. The average cycle threshold (Cq) values of the target genes were normalized to GAPDH gene expression level as 2^−ΔΔCq^ ([@b35-ol-0-0-6992]). Changes in expression levels were presented either as fold increases or as the ratio of the target gene expression in the treated cells to its expression level in the control cells.

### Western blotting

Six proteins involved in apoptosis (caspase-2, caspase-3, caspase-9, Bcl-2, Bak and Bax) were analyzed by western blotting. HCT-116 cells were exposed to GSPs (25, 50 or 100 µg/ml) at a concentration of 5×10^5^ cells/well for 48 h in 6-well plates, harvested and lysed in RIPA buffer (Pierce; Thermo Fisher Scientific, Inc.). Following a 30-min incubation on ice, the cell lysate was centrifuged at 10,000 × g at 4°C for 5 min and the supernatants were stored at −80°C until use. The protein concentrations were determined using the Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Proteins (30 µg) were separated by 12% SDS-PAGE, transferred to polyvinyl difluoride membranes (EMD Millipore, Billerica, MA, USA) and blocked using 5% non-fat dry milk in Tris-buffered saline (TBS) for 2 h at room temperature. The membranes were then incubated with 1:1,000 dilutions of the aforementioned primary antibodies in TBS overnight at 4°C, washed three times with TBS-Tween-20 and incubated with 1:5,000 dilutions of the appropriate secondary antibodies conjugated with HRP in TBS for 1 h at room temperature. Membranes were washed three times in TBS-Tween-20 at room temperature. Protein bands were visualized on X-ray film using an enhanced chemiluminescence (GE Healthcare, Chicago, IL, USA) detection system. Western blotting bands were quantified using the Odyssey infrared imaging system version 1.2 (LI-COR Biosciences, Lincoln, NE, USA).

### Statistical analysis

Data are presented as the mean ± standard deviations and all analyses were performed using Origin8 version 8.1.10.86 SRO (Origin8 Technologies Ltd., London, UK). Statistical significance was evaluated using two-way analysis of variance and Tukey\'s post hoc test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Effect of GSPs on HCT-116 cell viability and apoptosis

MTT assays of HCT-116 and HF-91 cells treated with GSPs (25, 50 or 100 µg/ml), 5-Fu (25 µg/ml) or solvent control indicated that GSPs reduced HCT-116 cell viability in a concentration-dependent manner, whereas the inhibition of GSPs in HF-91 cells was significantly lower compared with that in 5-Fu-treated cells (P\<0.01; [Fig. 1A](#f1-ol-0-0-6992){ref-type="fig"}). HCT-116 cells exposed to GSPs demonstrated cell shrinkage and membrane blebbing ([Fig. 1B](#f1-ol-0-0-6992){ref-type="fig"}). Annexin V/PI double staining of the treated and untreated cells revealed GSP concentration-dependent formation of apoptotic bodies in HCT-116 cells ([Fig. 2](#f2-ol-0-0-6992){ref-type="fig"}).

### GSP-mediated effects on p53, caspases and the Bcl-2 family

In the present study, the expression levels of p53 and cytochrome *c* increased in GSP-treated cells. Significant overexpression was observed in HCT-116 cells exposed to 100 µg/ml GSPs compared with 5-Fu, but not in those treated with lower concentrations of GSPs or with PBS (negative control; [Fig. 3](#f3-ol-0-0-6992){ref-type="fig"}).

Considering the significance of caspases to apoptosis, the present study determines the mRNA and protein expression levels of initiator caspases (caspase-2 and −9) and an effector caspase (caspase-3). Upregulation of the mRNAs encoding caspase-2, caspase-3 and caspase-9 were observed in HCT-116 cells exposed to GSPs for 48 h ([Fig. 4A](#f4-ol-0-0-6992){ref-type="fig"}). Furthermore, the expression levels of cleaved caspase-2, caspase-3 and caspase-9 protein were also significantly increased in cells exposed to 100 µg/ml GSPs compared with 5-Fu for 48 h ([Fig. 4B and C](#f4-ol-0-0-6992){ref-type="fig"}).

To further investigate the mechanism underlying GSP-induced apoptosis, the present study evaluated the mRNA and protein expression levels of Bcl-2, Bax and Bak by qPCR, and western blotting. The Bcl-2 expression level in 100 µg/ml GSPs group was significantly reduced compared with 5-Fu, whereas the expression levels of Bax and Bak were upregulated in HCT-116 cells exposed to GSPs for 48 h ([Fig. 5A-C](#f5-ol-0-0-6992){ref-type="fig"}).

### GSPs induce apoptosis via the mitochondrial pathway

Caspase-9 is involved in the mitochondrial apoptosis pathway and an increased expression level of cleaved caspase-9 therefore implied mitochondrial involvement in GSPs-induced apoptosis. JC-1 staining revealed that the percentage of cells with a loss of mitochondrial membrane potential increased from 18.7% in the negative control cells to 80.1% in the HCT-116 cells exposed to 100 µg/ml GSPs ([Fig. 6A](#f6-ol-0-0-6992){ref-type="fig"}). The percentage of apoptotic cells observed in [Fig. 6A](#f6-ol-0-0-6992){ref-type="fig"} is summarized in [Fig. 6B](#f6-ol-0-0-6992){ref-type="fig"}. This loss of mitochondrial membrane potential, coupled with the observed increase in cleaved caspase-9, suggested that GSPs induced HCT-116 cell death via the mitochondrial apoptosis pathway.

Discussion
==========

GSPs are observed in dietary botanical supplements and these compounds have been revealed to have anticarcinogenic properties ([@b12-ol-0-0-6992]--[@b18-ol-0-0-6992],[@b36-ol-0-0-6992]). However, the molecular mechanisms underlying their effects in CRC are not clearly understood.

The cell proliferation inhibitory results in the present study regarding GSP treatment on the CRC cell line (HCT-116) are in agreement with the concentration-dependent effects reported for cyanidin on human colon cancer cell lines HCT-15 and HT-29 ([@b37-ol-0-0-6992],[@b38-ol-0-0-6992]). However, GSPs revealed more active inhibition compared with cyanidin on colon cancer cells. This was accompanied by early and late apoptosis, and necrosis, observed using fluorescence microscopy and flow cytometry ([@b37-ol-0-0-6992],[@b38-ol-0-0-6992]). A series of experimental evidence suggested that GSPs are associated with the p53-induced mitochondrial apoptosis pathway, and involved with the Bcl-2 and caspase families ([@b39-ol-0-0-6992]). The Bcl-2 family consists of pro- and anti-apoptotic members that are associated with opposing effects on mitochondria. Bax and Bak regulate the release of cytochrome *c*, and the enhancement of cytochrome *c* activates caspase-2, −3 and −9 ([@b31-ol-0-0-6992],[@b32-ol-0-0-6992]). Caspase family proteins serve a key role in the regulation of p53-mediated apoptosis ([@b33-ol-0-0-6992]). Bax is a p53 target and a pro-apoptotic member of the Bcl-2 family of proteins ([@b40-ol-0-0-6992],[@b41-ol-0-0-6992]). Repression of anti-apoptotic members, including Bcl-2 and Bcl-xL, which are transcriptionally suppressed by p53 ([@b42-ol-0-0-6992]), preserves the integrity of the mitochondria. The present study demonstrated that GSPs upregulated the pro-apoptotic proteins (Bax and Bak) and caspase family proteins (caspase-2, −3 and −9), and downregulated the anti-apoptotic protein Bcl-2 in HCT-116 cells. It was observed that the increased expression level of Bcl-2 induced the decrease of mitochondrial potential and eventually lead to apoptosis ([@b43-ol-0-0-6992]). The results of the present study revealed that GSPs mediated the reduction of the mitochondrial membrane potential in a concentration-dependent manner. Based on these results, [Fig. 7](#f7-ol-0-0-6992){ref-type="fig"} presents a schematic of the proposed molecular mechanisms underlying these effects of GSPs. Exposure to GSPs activated cleavage of caspase-2, caspase-3 and caspase-9 in HCT-116 cells, induced p53-mediated mitochondrial apoptosis signaling pathway with a concentration-dependent decrease in the expression level of the survival protein Bcl-2, and increased the expression level of the pro-apoptotic proteins, Bax and Bak.

In conclusion, GSPs modulated the expression level and activation of numerous genes and proteins involved in the mitochondrial apoptotic pathway. These results proposed that GSPs prompted colon cancer cell apoptosis via the mitochondrial pathway and provided evidence demonstrating that GSPs may postulate potential chemotherapeutic agents for colorectal cancer.
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![GSP-mediated antiproliferative effects in HCT-116 cells. (A) MTT assay was performed in HCT-116 and HF-91 cells following treatment with GSPs or 5-Fu. Data is presented as the mean ± standard deviation of triplicate evaluations from one of three independent experiments. ^\#^P\<0.05, for the comparison with 5-Fu-treated cells; ^\#\#^P\<0.01, for the comparison with 5-Fu-treated cells. (B) HCT-116 cells revealed GSPs-induced cell shrinkage and membrane blebbing (scale bar, 500 µm). GSP, grape seed proanthocyanidins; 5-Fu, 5-fluorouracil.](ol-14-05-5853-g00){#f1-ol-0-0-6992}

![GSP-mediated induction of apoptosis in HCT-116 cells. Annexin V/propidium iodide staining analysis of HCT-116 cells were analyzed by flow cytometry following GSPs or 5-Fu treatment. Normal cells are presented in green and apoptotic cells are presented in red (scale bar, 500 µm). GSP, grape seed proanthocyanidins; 5-Fu, 5-fluorouracil.](ol-14-05-5853-g01){#f2-ol-0-0-6992}

![Effects of GSPs on mRNA expression levels of p53 and cytochrome C in HCT-116 cells. Quantitative-polymerase chain reaction analyses of (A) p53 and (B) cytochrome *c* mRNA expression levels in HCT-116 cells exposed to GSPs or 5-Fu. Data is presented as the means ± standard deviation of triplicate measurements from one of three independent experiments. \*P\<0.05 for the comparison with control (PBS treated); ^\#^P\<0.05 for the comparison with 5-Fu-treated cells. GSP, grape seed proanthocyanidins; 5-Fu, 5-fluorouracil.](ol-14-05-5853-g02){#f3-ol-0-0-6992}

![Effects of GSPs on the expression levels of caspase family in HCT-116 cells. (A) Quantitative-polymerase chain reaction analyses of caspase-2, caspase-3 and caspase-9 in HCT-116 cells exposed to GSPs or 5-Fu. (B) Western blot analysis of caspase-2, caspase-3 and caspase-9 in HCT-116 cells exposed to GSPs or 5-Fu. (C) Expression levels were normalized to β-actin and are relative to the control. \*P\<0.05 for the comparison with control (PBS treated); ^\#^P\<0.05 for the comparison with 5-Fu-treated cells. GSP, grape seed proanthocyanidins; 5-Fu, 5-fluorouracil.](ol-14-05-5853-g03){#f4-ol-0-0-6992}

![Effects of GSPs on the expression level of the Bcl-2 family in HCT-116 cells. (A) Quantitative-polymerase chain reaction analyses of Bcl-2, Bak and Bax in HCT-116 cells exposed to GSPs or 5-Fu. (B) Western blot analysis of Bcl-2, Bak and Bax in HCT-116 cells exposed to GSPs or 5-Fu. (C) Expression levels were normalized to β-actin and are relative to the control. \*P\<0.05 for the comparison with control (PBS treated); ^\#^P\<0.05 for the comparison with 5-Fu-treated cells. GSP, grape seed proanthocyanidins; 5-Fu, 5-fluorouracil; Bcl-2, B cell lymphoma-2; Bak, Bcl-2 homologous antagonist/killer; Bax, apoptosis regulator Bax.](ol-14-05-5853-g04){#f5-ol-0-0-6992}

![GSPs induce apoptosis in HCT-116 via the mitochondrial pathway. (A) JC-1 staining of HCT-116 cells exposed to GSPs or 5-Fu. Apoptotic cells are presented in the lower right quadrant of the dot plots. (B) Percentage of HCT-116 cells undergoing apoptosis following treatment with GSPs or 5-Fu, according to the JC-1 assay. Data is presented as the mean ± standard deviation of triplicates from one of three independent experiments. \*P\<0.05 for the comparison with control; ^\#^P\<0.05 for the comparison with 5-Fu-treated cells. GSP, grape seed proanthocyanidins; 5-Fu, 5-fluorouracil; PI, propiduim iodide.](ol-14-05-5853-g05){#f6-ol-0-0-6992}

![Mechanism diagram for the effects of GSPs in HCT-116 cells. GSPs modulate the expression and activation of numerous genes associated with the mitochondrial apoptotic pathway. GSP, grape seed proanthocyanidins; Bcl-2, B cell lymphoma-2; MMP, matrix metalloproteinase; Bak, Bcl-2 homologous antagonist/killer; Bax, apoptosis regulator Bax.](ol-14-05-5853-g06){#f7-ol-0-0-6992}

###### 

Quantitative polymerase chain reaction primer sequences.

  Gene           Primer sequence (5′-3′)
  -------------- -------------------------------------
  Bcl-2          Forward: CATGTGTGTGGAGAGCGTCAA
                 Reverse: GCCGGTTCAGGTACTCAGTCA
  Bax            Forward: GATCCAGGATCGAGCAGA
                 Reverse: AAGTAGAAGAGGGCAACCAC
  Bak            Forward: AGATAGATAGCAGTAGTGCCTCA
                 Reverse: ATTGCCAGTAGAAGCTCTCATGGTT
  Caspase-2      Forward: CAAGTTCCTGAGCCTGGACTACATT
                 Reverse: GACAGATTGCTTTCCTCCAACATT
  Caspase-3      Forward: CAGAACTGGACTGTGGCATTGAG
                 Reverse: GGATGAACCAGGAGCCATCCT
  Caspase-9      Forward: GCGAACTAACAGGCAAGCAGC
                 Reverse: CGACATCACCAAATCCTCCAGAAC
  Cytochrome C   Forward: GGTCAACAAATCATAAAGATATTGG
                 Reverse: TAAACTTCAGGGTGACCAATAAATCA
  p53            Forward: GCGGACTAACAGGCAAGCAAC
                 Reverse: CTCGTTTATACTCCTCCAGAAC
  GAPDH          Forward: CGGAGTCAACGGATTTGGTCGTAT
                 Reverse: AGCCTTCTCCATGGTTGGTGAAGAC

BCL-2, B cell lymphoma-2; Bak, Bcl-2 homologous antagonist/killer; Bax, apoptosis regulator Bax.
